Work

Response Rate of 16% and High Incidence of Adverse Events In Placebo-Treated Patients with CD25 Assay-Positive Cutaneous T-Cell Lymphoma (CTCL): An Analysis of Patient Characteristics and Predictors of Response

Year: 2010

Type: article

Source: Blood

DOI: 10.1182/blood.v116.21.4158.4158

Authors: Miles Prince, Madeleine Duvic, Ann Martin, Wolfram Sterry, Chalid Assaf, David Straus

Institutions: Peter MacCallum Cancer Centre, The University of Texas MD Anderson Cancer Center, Washington University in St. Louis, Charité – Universitätsmedizin Berlin, Helios Klinikum Krefeld, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979374478

FWCI:

Cites:

Cited by:

Related to: 10